— Early sign of Alzheimer's reversed in lab — One of the earliest known impairments caused by Alzheimer's disease - loss of sense of smell - can be restored by removing a plaque-forming protein in a mouse model of the disease,…
— Parental controls on embryonic development? — When a sperm fertilises an egg, each contributes a set of chromosomes to the resulting embryo, which at these very early stages is called a zygote. Early on, zygotic genes are inert,…
— Newly discovered heart stem cells make muscle and bone — Researchers have identified a new and relatively abundant pool of stem cells in the heart. The findings in the December issue of Cell Stem Cell, a Cell Press publication, show that…
— BUSM researchers develop blood test to detect membranous nephropathy — Research conducted by a pair of physicians at Boston University School of Medicine (BUSM) and Boston Medical Centre (BMC) has led to the development of a test that can help diagnose…
— New hip implants no better than traditional implants — New hip implants appear to have no advantage over traditional implants, suggests a review of the evidence published on bmj.com today…
— Action needed to improve men's health in Europe — Policies aimed specifically at men are urgently needed to improve the health of Europe's men, say experts on bmj.com today…
— Probiotics reduce infections for patients in intensive care — Traumatic brain injury is associated with a profound suppression of the patient's ability to fight infection. At the same time the patient also often suffers hyper-inflammation, due…
— High blood sugar levels in older women linked to colorectal cancer — Elevated blood sugar levels are associated with an increased risk of colorectal cancer, according to a study led by researchers at Albert Einstein College of Medicine of Yeshiva University.…
— Engineered botulism toxins could have broader role in medicine — The most poisonous substance on Earth - already used medically in small doses to treat certain nerve disorders and facial wrinkles - could be re-engineered for an expanded role in helping…
Biochemical pathway may link addiction, compulsive eating
Ezlopitant, a compound known to suppress craving for alcohol in humans, was shown to decrease consumption of sweetened water by rodents in a study by researchers at the Ernest Gallo Clinic and Research Centre, which is affiliated with the University of California, San Francisco.
'This finding suggests a possible link between the neurochemical pathways for addiction and compulsive eating,' says principal investigator Selena Bartlett, PhD, Director of the Pre-Clinical Development Group at the Gallo Centre.
The study will be published online in PLoS One on September 1, 2010.
Ezlopitant is an NK1 receptor-antagonist, a class of drugs that blocks the action of substance P, a neurotransmitter that is believed to play a role in the reward system. The reward system is a complex of brain structures that, among other things, governs craving for, and addiction to, alcohol and drugs.
'Substance P is released in your brain in response to certain stimuli, and needs to bind with receptors on neurones in order to have an effect,' Bartlett explains. 'The NK1 receptor is where it binds, and ezlopitant prevents that binding.'
In the study, rats given ezlopitant showed significantly decreased motivation to consume water sweetened with sugar, water sweetened with saccharin, and an alcohol solution.
Bartlett believes one possible explanation is that the NK1 receptor is part of the same reward system that links compulsive craving for sweets with craving for drugs and alcohol.
'In other studies, NK1-receptor antagonists have been shown to decrease craving for alcohol in humans with alcohol-use disorder,' she says. 'In our study, the decrease in the rats' consumption of sweetened water was, in fact, even greater than their decrease in alcohol consumption. For the first time, we've shown that this receptor might be a target for compulsive eating. We're looking at a potentially promising new approach to addressing pathological food addiction.
Bartlett notes that her laboratory is focused on the development of medications for human use, so, 'naturally,' she says, 'we'd like to see this experiment replicated in humans as soon as possible.'
Or subscribe for our Newsletter, a free e-mail publication. It is published practically every day.
Ugandan monkeys harbour evidence of infection with unknown poxvirus
Research may lead to improved hearing for some
Novel method of measuring insulin promises improvements in diabetes treatment
Gene variant increases risk of asthma